Considering that IL-1β perpetuates immune responses and contributes to disease severity in stroke, multiple sclerosis, neurodegenerative diseases, and diabetic retinopathy [62], it would be interesting to examine whether application of miR-331 mimics is also beneficial for enhancing neuronal recovery in these CNS diseases. Here, IL1B is linked to diabetic retinopathy.